MDT

89.1

+0.54%↑

VEEV

283.96

+1.41%↑

A

121.45

+0.27%↑

WBA

11.56

+0.35%↑

HQY

99.61

-3.32%↓

MDT

89.1

+0.54%↑

VEEV

283.96

+1.41%↑

A

121.45

+0.27%↑

WBA

11.56

+0.35%↑

HQY

99.61

-3.32%↓

MDT

89.1

+0.54%↑

VEEV

283.96

+1.41%↑

A

121.45

+0.27%↑

WBA

11.56

+0.35%↑

HQY

99.61

-3.32%↓

MDT

89.1

+0.54%↑

VEEV

283.96

+1.41%↑

A

121.45

+0.27%↑

WBA

11.56

+0.35%↑

HQY

99.61

-3.32%↓

MDT

89.1

+0.54%↑

VEEV

283.96

+1.41%↑

A

121.45

+0.27%↑

WBA

11.56

+0.35%↑

HQY

99.61

-3.32%↓

Search

PerkinElmer Inc

Fechado

SetorSaúde

0

Visão Geral

Variação de preço das ações

24h

Atual

Mín

Máximo

Indicadores-chave

By Trading Economics

Rendimento

-53M

42M

Vendas

-65M

665M

P/E

Médio do Setor

40.789

39.564

EPS

1.01

Rendimento de Dividendos

0.29

Margem de lucro

6.268

Funcionários

11,000

EBITDA

-50M

173M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+16.3% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

0.29%

2.40%

Próximos Ganhos

28 de jul. de 2025

Próxima data de dividendos

8 de ago. de 2025

Próxima data de ex-dividendo

18 de jul. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-2.4B

12B

Abertura anterior

0

Fecho anterior

0

Sentimento de Notícias

By Acuity

26%

74%

54 / 376 Ranking em Healthcare

PerkinElmer Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

9 de jul. de 2025, 15:46 UTC

Grandes Movimentos do Mercado

BitMine Shares Fall After Closing of $250 Million Private Placement

9 de jul. de 2025, 23:44 UTC

Conversa de Mercado

Gold Edges Higher Amid U.S. Tariff Concerns -- Market Talk

9 de jul. de 2025, 23:42 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

9 de jul. de 2025, 23:42 UTC

Conversa de Mercado

Nikkei May Trade Rangebound as U.S. Tariff Uncertainty Continues -- Market Talk

9 de jul. de 2025, 22:59 UTC

Conversa de Mercado

Reliance Worldwide's Costs at Risk From Copper Tariffs -- Market Talk

9 de jul. de 2025, 22:59 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

9 de jul. de 2025, 20:50 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Health Care Roundup: Market Talk

9 de jul. de 2025, 20:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

9 de jul. de 2025, 20:26 UTC

Ganhos

Nvidia Is the Most Valuable Company Ever. Why $5 Trillion Could Be Next. -- Barrons.com

9 de jul. de 2025, 19:18 UTC

Conversa de Mercado

Oil Futures End Little Changed After Big U.S. Crude Stock Build -- Market Talk

9 de jul. de 2025, 19:03 UTC

Conversa de Mercado

U.S. Natural Gas Posts Back-to-Back Losses -- Market Talk

9 de jul. de 2025, 18:31 UTC

Conversa de Mercado

Some Fed Officials Supported Considering July Cut -- Market Talk

9 de jul. de 2025, 17:07 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Honeywell's Streamlining Efforts Clear Path for Stock to Catch Up -- Market Talk

9 de jul. de 2025, 16:20 UTC

Conversa de Mercado

Financial Services Roundup: Market Talk -2-

9 de jul. de 2025, 16:20 UTC

Conversa de Mercado

Financial Services Roundup: Market Talk

9 de jul. de 2025, 16:20 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Health Care Roundup: Market Talk

9 de jul. de 2025, 16:20 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

9 de jul. de 2025, 16:15 UTC

Conversa de Mercado

Global Commodities Roundup: Market Talk

9 de jul. de 2025, 16:14 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

9 de jul. de 2025, 16:14 UTC

Conversa de Mercado

Rents in Canada Soften For Ninth-Straight Month -- Market Talk

9 de jul. de 2025, 16:14 UTC

Aquisições, Fusões, Aquisições de Empresas

Apple Has Dropped the Ball on AI. Buying Perplexity Could Help It Catch Up, Say Analysts. -- Barrons.com

9 de jul. de 2025, 16:12 UTC

Conversa de Mercado

Gold Futures Broadly Flat in Largely Directionless Trade -- Market Talk

9 de jul. de 2025, 16:08 UTC

Conversa de Mercado

Oil Ticks Higher Amid Large U.S. Crude Build, Red Sea Tensions, Tariff Uncertainty -- Market Talk

9 de jul. de 2025, 15:31 UTC

Grandes Movimentos do Mercado

BitMine Shares Fall After Closing of $250M Private Placement

9 de jul. de 2025, 15:31 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

With Competing Bids Unlikely, Merck's Path to Acquiring Verona Looks Smooth -- Market Talk

9 de jul. de 2025, 15:27 UTC

Conversa de Mercado

Copper Rally Expected to Fade Amid Tepid Global Demand -- Market Talk

9 de jul. de 2025, 14:36 UTC

Aquisições, Fusões, Aquisições de Empresas

Merck to Buy Verona Pharma in $10 Billion Deal -- 2nd Update

9 de jul. de 2025, 14:31 UTC

Aquisições, Fusões, Aquisições de Empresas

Meta Has Surged on the Back of AI Software. Why Hardware Is the Next Play. -- Barrons.com

9 de jul. de 2025, 14:26 UTC

Conversa de Mercado

Market Talk Roundup: Latest on U.S. Politics

9 de jul. de 2025, 14:26 UTC

Conversa de Mercado

Aug 1 Tariffs Will Boost Average Rate Near 15%, JPMorgan Estimates -- Market Talk

Comparação entre Pares

Variação de preço

PerkinElmer Inc Previsão

Preço-alvo

By TipRanks

16.3% parte superior

Previsão para 12 meses

Média 117.07 USD  16.3%

Máximo 135 USD

Mínimo 100 USD

Com base em 14 analistas de Wall Street que oferecem metas de preço de 12 meses para PerkinElmer Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

14 ratings

9

Comprar

5

Manter

0

Vender

Sentimento

By Acuity

54 / 376 Ranking em Saúde

Sentimento de Notícias

Evidência de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre PerkinElmer Inc

Revvity, Inc. provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific,BoBs , chemagic, Chitas, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, explorer, Fontus, Genoglyphix, GSP, Haoyuan, IDS, IDS-i10 IDS-i10T, IDS-iSYS, iLab, iQ, JANUS, LabChip, LifeCycle, LimsLink, Migele, MultiPROBE, NEXTFLEX, NextPrep, Pannoramic, Panthera Puncher, PG-Seq, PGFind PKamp, PreNAT II, Prime, Protein Clear, ProteinEXact, QSigh, QuantiVac, RONIA, Sciclone, SimplicityChrom, Specimen Gate,Superflex, Symbio, T-SPOT, Touch, Twister, Vanadis, VariSpec, ViaCord VICTOR 2D, and Zephyr brand name. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.